Results 111 to 120 of about 168,140 (338)
Laryngeal Preservation Strategies in Locally Advanced Laryngeal and Hypopharyngeal Cancers. [PDF]
, 2019 For long, the treatment of locoregionally advanced laryngeal and hypopharyngeal squamous cell cancers (SCC) consisted of either total laryngectomy (TL) or definitive radiotherapy (RT).
Argiris, Athanassios +1 more
core +2 more sources
Adverse effects of chemoradiotherapy on invasion and metastasis of tumor cells
Genes and Diseases, 2020 The phenomenon of enhanced invasion and metastasis of residual tumor cells has been observed in an increasing number of patients receiving chemoradiotherapy recently, and tumor metastasis will undoubtedly limit patient prognosis.
Wei Xiong +4 more
doaj
Gastroenterology Research and Practice, 2017 Background. Preoperative chemoradiotherapy is the standard treatment for patients with locally advanced rectal cancer, although tumor responses vary widely; some patients may achieve a pathologic complete response rate (pCR) after chemoradiotherapy ...
Min Chen +5 more
doaj +1 more source
Frontiers in Cell and Developmental Biology, 2020 BackgroundN6-methyladenosine (m6A) RNA methylation and tumor immune microenvironment played crucial roles in cancer development. However, their association in gliomas remains to be fully elucidated.MethodsA total of 2144 glioma patients from CGGA, TCGA ...
Shengchao Xu +4 more
doaj +1 more source
Journal of Clinical Oncology, 2012 PURPOSE Preoperative chemoradiotherapy (CRT) has been established as standard treatment for locally advanced rectal cancer after first results of the CAO/ARO/AIO-94 [Working Group of Surgical Oncology/Working Group of Radiation Oncology/Working Group of ...
R. Sauer +12 more
semanticscholar +1 more source
Annals of Gastroenterological Surgery, EarlyView.This multi‐institutional, randomized, phase II trial aimed to investigate the long‐term survival outcomes of two versus three courses of DCF for locally advanced esophageal squamous cell carcinoma (ESCC). The 5‐year overall survival and progression‐free survival rates for the three and two course groups were 70.7% vs. 63.8% (hazard ratio (HR) = 0.91, p
Takahito Sugase +19 more
wiley +1 more source
Gastroenterology Research and Practice, 2013 Background. Little data on directly comparing chemoradiotherapy with observation has yet been published in the setting of adjuvant therapy for resected gastric cancer who underwent D2 lymphadenectomy.
Qiong Yang +5 more
doaj +1 more source
World Journal of Surgical Oncology, 2017 Background There are only two prospective, randomized studies comparing preoperative long-term chemoradiotherapy and postoperative chemoradiotherapy in locally advanced rectal cancer (LARC); however, conflicting results in terms of locoregional ...
Erhan Akgun +9 more
doaj +1 more source
The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
Frontiers in Oncology, 2020 Chemoradiotherapy as an alternative to surgery can be offered to patients affected by loco-regionally advanced head and neck cancer (HNC). Induction chemotherapy is a valid option, supported by few positive trials, but its real efficacy is still a matter
Daris Ferrari +5 more
doaj +1 more source
Electronic swallowing intervention package to support swallowing function in patients with head and neck cancer: development and feasibility study [PDF]
, 2018 Background: Many patients undergoing treatment for head and neck cancer (HNC) experience significant swallowing difficulties, and there is some evidence that swallowing exercises may improve outcomes, including quality of life.
Boa, Sally +4 more
core +2 more sources